SCHEMBL23933171

SCHEMBL23933171

C1C2[C@H]3C[C@H]3[C@@H]1[C@H]1C[C@@H]21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25905106 0.77
SCHEMBL31522374 0.72
SCHEMBL19017169 0.72
SCHEMBL23881943 0.71 ALDH1A1 (0.35)
Water SCHEMBL27697076 0.68
Hydrogen Sulfide SCHEMBL27493954 0.68
SCHEMBL27738029 0.68
Water SCHEMBL27908069 0.68
SCHEMBL27895016 0.68
Phosphine SCHEMBL27604167 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4139296-A1 COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR Opna Immuno Oncology, SA (CH) 2023-03-01 EP disclosed
WO-2021216898-A1 COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2021-10-28 WO disclosed